The evidence for puberty blockers and cross-sex hormones for young people with gender dysphoria is “remarkably weak”. That’s according to the Cass Review, a new in-depth report commissioned by NHS England.

As you might imagine, the report’s conclusions have been somewhat controversial. In this paid-subscriber-only episode of The Studies Show, Tom and Stuart read through the Cass Report, consider the arguments of its critics, and try to put the whole thing in context.